ArticleCell death discovery2017

Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines.

Johanna Huun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.